Chemical Compound
Rivastigmine Tartrate; Rivastigmine hydrogen tartrate; 3-[(1S)-1-(Dimethylamino)ethyl]phenyl ethyl(methyl)carbamate hydrogen (2R,3R)-2,3-dihydroxybutanedioate; Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)Carbamic acid, ethylmethyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (9CI); Carbamic acid, ethylmethyl-, 3-[1-(dimethylamino)ethyl]phenyl ester, (S)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1); ENA 713; Rivastigmine hydrogentartrate; Rivastigmine tartrate; SDZ-ENA 713; rivastigmine bitartrate
CAS Registry Number
129101-54-8
Primary record
Rivastigmine Tartrate; Rivastigmine hydrogen tartrate; 3-[(1S)-1-(Dimethylamino)ethyl]phenyl ethyl(methyl)carbamate hydrogen (2R,3R)-2,3-dihydroxybutanedioate; Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)Carbamic acid, ethylmethyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (9CI); Carbamic acid, ethylmethyl-, 3-[1-(dimethylamino)ethyl]phenyl ester, (S)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1); ENA 713; Rivastigmine hydrogentartrate; Rivastigmine tartrate; SDZ-ENA 713; rivastigmine bitartrate
- 库存
- 7,478 克
- 纯度
- 99.7 %
- CAS
- 129101-54-8
化合物标识与属性
- CAS
- 129101-54-8
- PubChem CID
- 6918078
- SMILES
- CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
- Canonical SMILES
- CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O
名称与同义词
- Rivastigmine tartrate
- Exelon
- Rivastigmine Hydrogen Tartrate
- 129101-54-8
- Rivastigmine bitartrate
- rivastigmine
- Prometax
- Rivastach
- Rivastigmine actavis
- Rivastigmine (tartrate)
- Rivastigmine hydrogentartrate
- SDZ-ENA 713
- Exelon MR
- ENA 713
- Exelon TDS
- Nimvastid (TN)
- Exelon (TN)
- Rivastigmine L-Tartrate
- Rivastigmine Tartrate Salt
- ENA-713
- Rivastigmine tartrate;
- AC1OCEZZ
- RefChem:56915
- 9IY2357JPE
- UNII-9IY2357JPE
- SDZ ENA 713
- SDZ-ENA-713
- Rivastigmine tartrate (Exelon)
- MFCD03700731
- Rivastigmine tartrate [USP]
- CHEBI:64358
- MLS006011143
- ENA-713D
- orb1307975
- Rivastigmine Hydrogen Tartrate;
- CHEMBL1201092
- DTXCID4027818
- DTXSID8047840
- SCHEMBL29779663
- GWHQHAUAXRMMOT-MBANBULQSA-N
- BH001
- C18H28N2O8
- HMS3678F17
- HMS3884H05
- Rivastigmine for system suitability
- Rivastigmine hydrogen tartrate CRS
- ACT03355
- MSK11245
- ONO-2540
- Rivastigmine (tartrate) (Standard)
- C14H22N2O2.C4H6O6
- FC0001
- HY-11017R
- RIVASTIGMINE TARTRATE [VANDF]
- s2087
- AKOS022179413
- RIVASTIGMINE TARTRATE [USP-RS]
- (1S)-1-(2,4-dichlorophenyl)ethanol
- (S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate
- AC-3487
- ACN-034451
- CCG-213410
- CID6918078
- CS-0947
- FR15395
- Rivastigmine for system suitability CRS
- RL01405
- T01R548
- KS-00000H19
- SDZ-212-713
- AS-13921
- BC225685
- BR164357
- DA-67229
- HY-11017
- LS-49754
- Rivastigmine tartrate - Bio-X trade mark
- SMR004702920
- RIVASTIGMINE (AS HYDROGEN TARTRATE)
- RIVASTIGMINE HYDROGEN TARTRATE [MI]
- RIVASTIGMINE TARTRATE [ORANGE BOOK]
- AB2000491
- A8515
- AM20080949
- C14-H22-N2-O2.C4-H6-O6
- FT-0656529
- R0093
- RIVASTIGMINE TARTRATE [USP MONOGRAPH]
- ST24036084
- SW199663-2
- RIVASTIGMINE HYDROGEN TARTRATE [MART.]
- A11719
- D02558
- K-4017
- RIVASTIGMINE HYDROGEN TARTRATE [WHO-DD]
- RIVASTIGMINE HYDROGEN TARTRATE [EMA EPAR]
- A805907
- A966296
- (2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
- Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- RIVASTIGMINE HYDROGEN TARTRATE [EP MONOGRAPH]
- Q27133236
- N0001-009479
- (2R,3R)-2,3-dihydroxybutanedioic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate
- [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
- 3-[(S)-1-(Dimethylamino)ethyl]phenyl N-Ethyl-N-methylcarbamate L-Tartrate
- Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
- CARBAMIC ACID, N-ETHYL-N-METHYL-, 3-((1S)-1-(DIMETHYLAMINO)ETHYL)PHENYL ESTER, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE (1:1)
- N-Ethyl-N-methylcarbamic Acid 3-[(1S)-1-(Dimethylamino)ethyl]phenyl Ester (2R,3R)-2,3-Dihydroxybutanedioate
- (S)-N-Ethyl-3-[(1-dimethylamino)ethyl]-N-methylphenylcarbamate hydrogen tartrate
- N-Ethyl-N-methylcarbamic Acid 3-[(S)-1-(Dimethylamino)ethyl]phenyl Ester L-Tartrate
- Rivastigmine tartrate, 98%, acetylcholinesterase and butyrylcholinesterase inhibitor - 1G 1g
- (1S)-1-(3-{[ethyl(methyl)carbamoyl]oxy}phenyl)-N,N-dimethylethanaminium (2R,3R)-3-carboxy-2,3-dihydroxypropanoate
- (2R,3R)-2,3-dihydroxybutanedioic acid; [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
- (2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methyl-carbamate
- (S)-Ethylmethylcarbamic Acid 3-[1-(Dimethylamino)ethyl]phenyl Ester [R-(R*,R*)]-2,3-Dihydroxybutanedioate
- 179237-92-4
- 3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxybutanedioate
- 406174-29-6
- Carbamic Acid, Ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl Ester,(2R,3R)-2,3-dihydroxybutanedioate(1:1)
- Carbamic acid,ethylmethyl-,3-((1S)-1-(dimethylamino)ethyl)phenyl ester,(2R,3R)-2,3-dihydroxybutanedioate
- Carbamic acid,N-ethyl-N-methyl-,3-[(1S)-1-(dimethylamino)ethyl]phenyl ester,(2R,3R)-2,3-dihydroxybutanedioate (1:1)
- Rivastigmine Tartrate; Rivastigmine hydrogen tartrate; 3-[(1S)-1-(Dimethylamino)ethyl]phenyl ethyl(methyl)carbamate hydrogen (2R,3R)-2,3-dihydroxybutanedioate; Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)Carbamic acid, ethylmethyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (9CI); Carbamic acid, ethylmethyl-, 3-[1-(dimethylamino)ethyl]phenyl ester, (S)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1); ENA 713; Rivastigmine hydrogentartrate; Rivastigmine tartrate; SDZ-ENA 713; rivastigmine bitartrate